Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New silver dressing aims to speed burn recovery

NCT ID NCT05824026

Symptom relief Sponsor: Coloplast A/S Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a special wound dressing with silver on 52 adults with partial-thickness burns that were infected or at risk of infection. Participants wore the dressing for two weeks, with changes once a week. The main goal was to see how many wounds healed within 14 days.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
gelling fiber wound dressing with silver
What this could lead to
If successful, this dressing could offer a simple way to help burn wounds heal faster and reduce infection risk.
What could go wrong
This was a small, completed study with only 52 participants, so results may not apply to everyone. The dressing is a device, not a cure, and healing depends on many factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

52 people

The number who actually took part.

Started

Oct 2023

Finished

Apr 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Has signed informed consent 2. Is between 18 -65 years (both included) 3. Is capable of following study procedure (assessed by investigator). 4. Has a partial thickness burn wound 5. Has a burn wound that is infected or at risk of infection (assessed by investigator) 6. The size of burn (including both study wound and non-study injuries) has a Total Body Surface Area (TBSA) less than 10% (assessed by investigator). 7. The wound should fit under a 20x30 cm dressing (600 cm2) or smaller 8. The shape and location of the wound should be suitable for photo capture (assessed by the investigator). 9. Has a wound that has medium to high level of exudate (assessed by the investigator) 10. Is suitable to use the test product for wound treatment (assessed by the investigator). Exclusion Criteria: 1. Is pregnant/breastfeeding 2. Is currently receiving or has within the past 60 days received radio- and/or chemotherapy (low doses radio- and/or chemotherapy is allowed for other indications than cancer if assessed by investigator not to influence study wound area) 3. Known history of skin sensitivity to any components of the test dressings 4. \>72 hours from time of injury 5. Intake of antibiotics within one week before the start of the enrolment 6. Use of chemical debridement 7. Participation in any other clinical studies that can compromise this study treatment (assessed by the investigator).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Partial thickness burn are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Partial thickness burn

Contacts and locations

Locations

  • Buckinghamshire Healthcare NHS Trust

    Aylesbury, Buckinghamshire, HP21 8AL, United Kingdom

  • Newcastle University/The Newcastle upon Tyne Hospitals NHS Foundation Trust

    Newcastle, NE3 3HD, United Kingdom

  • North Bristol Southmead Hospital

    Westbury, Bristol, BS10 5NB, United Kingdom

  • Queen Alexandra Hospital, Portsmouth Hospital University Trust

    Cosham, P06 3LY, United Kingdom

  • Queen Victoria Hospital NHS foundation trust

    East Grinstead, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.